ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $922,350 | +124710.6% | 82,500 | -26.3% | 0.00% | +33.3% |
| Q1 2024 | $739 | +218.5% | 112,000 | +117.9% | 0.00% | +200.0% |
| Q4 2023 | $232 | +26.1% | 51,400 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $184 | +64.3% | 51,400 | +68.5% | 0.00% | – |
| Q2 2023 | $112 | – | 30,500 | +7525.0% | 0.00% | – |
| Q1 2021 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 400 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 400 | -50.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 800 | +100.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 400 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 400 | -92.7% | 0.00% | – |
| Q3 2018 | $34,000 | +41.7% | 5,500 | 0.0% | 0.00% | – |
| Q2 2018 | $24,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |